PHParham Hadikhani

Parham Hadikhani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Parham Hadikhani has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Asthma Exacerbations: Integrative Analysis of miRNA Activity Using Single-Cell Transcriptomics

    by Parham Hadikhani, Xiting Yan, Geoffrey Chupp, Ga Young Ban, Shraddha Piparia, Michael McGeachie, Rinku Sharma, Scott T. Weiss, Louise C. Laurent, Alvin T Kho, et al.

    Background: Asthma exacerbations are caused by dysregulated cellular interactions between airway and immune cell populations. Circulating microRNAs (miRNAs) are potential biomarkers for asthma exacerbations; however, their target airway cells remain poorly defined. Objective: To identify the cell types that are regulated by the circulating microRNAs linked to asthma exacerbations and the extent to which the cells are regulated by miRNAs. Methods: We integrated a curated panel of exacerbation-associated circulating miRNAs with single-cell RNA sequencing (scRNA-seq) profiles from induced sputum of 16 asthma patients and 8 healthy controls. Experimentally validated miRNA-target interactions were combined with cell-type-specific differential expression. Elastic Net regression and SHAP analysis quantified gene-level regulatory contributions, yielding a composite Regulation Strength metric. Findings were validated against four independent GEO datasets. Results: Immune cells, including monocytes, dendritic cells, and macrophages, demonstrated the strongest statistically significant miRNA regulatory signals, in contrast to airway epithelial cells.hsa-miR-222-3p showed opposing regulatory effects in mature versus alveolar macrophages, indicating differentiation-state-dependent activity, while B_Plasma cells showed no detectable regulatory effect from any miRNA tested. Independent GEO validation confirmed higher expression of protective miRNAs (hsa-miR-126-3p, hsa-miR-146b-5p) in healthy individuals, consistent with prior CAMP cohort associations. Conclusion: Circulating miRNAs show cell-type-specific regulatory activity, strongest in monocytes, dendritic cells, and macrophages. hsa-miR-222-3p showed opposing regulatory directions between macrophage subtypes, while B_Plasma cells showed no effect, validated across independent GEO cohorts.

  • Open Access

    Circulating microRNAs Predict Longitudinal Asthma Control and Treatment Response

    by Parham Hadikhani, Alvin T Kho, Shraddha Piparia, Rinku Sharma, Scott T. Weiss, Michael McGeachie, Kelan G. Tantisira

    Background: GINA-based clinical assessment of asthma control provides limited insight into the molecular mechanisms driving disease progression and treatment response. Circulating microRNAs (miRNAs) are implicated in immune regulation and airway remodeling, but their relationship to longitudinal, treatment-specific asthma control is not well characterized. We aimed to identify treatment-specific miRNAs associated with longitudinal asthma control and evaluate their ability to discriminate well-controlled from uncontrolled asthma. Methods: Baseline serum miRNA sequencing data from 491 children in the Childhood Asthma Management Program (CAMP), a randomized trial of budesonide versus placebo, were analyzed, with GINA-based composite symptom scores assessed at baseline and 2, 4, 8, and 12 months. Cumulative link mixed models were fitted across 266 miRNAs to identify associations with longitudinal ordinal asthma control, adjusting for time, baseline status, and treatment. Random Forest classifiers were trained within each treatment group using Group K-Fold cross-validation. Pathway enrichment of validated miRNA targets was performed with DAVID. Results: In the budesonide group, hsa-miR-1224-5p was associated with lower symptom severity and hsa-miR-199a-3p|hsa-miR-199b-3p with higher severity; both associations persisted at 12 months. The placebo group showed a broader pattern, with ten miRNAs associated with symptoms. Random Forest classifiers achieved mean AUC of 0.776 (budesonide) and 0.714 (placebo) for 12-month control status. Budesonide-associated targets were enriched for glucocorticoid-responsive and MAPK/Ras signaling, while placebo-associated targets showed broad enrichment for general regulatory processes. Conclusion: Treatment-specific circulating miRNAs distinguish asthma control over time and implicate distinct signaling pathways, supporting their potential as complementary molecular markers for asthma monitoring in children.

  • Open Access

    MicroRNAs in Asthma: A Replication-Based Review of Human Evidence

    by Parham Hadikhani, Shraddha Piparia, Rinku Sharma, Michael McGeachie, Kelan Tantisira

    Asthma is a heterogeneous inflammatory airway disease characterized by diverse endotypes, variable clinical severity, and differential treatment responses driven by genetic, epigenetic, and environmental influences. MicroRNAs (miRNAs), as post-transcriptional regulators of gene expression, are central modulators of airway inflammation, remodeling, and immune dysregulation and represent promising candidates for biomarker development and therapeutic targeting. Despite the growing literature on dysregulated miRNAs in asthma, findings remain inconsistent and frequently lack independent validation. Using a structured search strategy covering 2009–2025, we identified 299 records and applied predefined replication criteria to prioritize reproducible associations. Two complementary validation Criteria were implemented: cross-study replication across independent cohorts and discovery–replication study designs addressing clinical heterogeneity. This approach yielded 49 cross-study replicated and 10 discovery–replication validated journal articles, substantially narrowing the field to a focused set of high-confidence miRNA candidates. Among the most consistently replicated miRNAs, miR-146a and miR-1246 emerged as central regulators linked to NF-κB signaling, epithelial dysfunction, and corticosteroid responsiveness. Replicated miRNAs demonstrated compartment-specific expression across airway epithelium, smooth muscle, immune cells, and circulating fractions, and were associated with clinically relevant dimensions including disease severity, exacerbation frequency, lung function variability, and treatment response. Genetic, epigenetic, and environmental influences further support their biological plausibility. By consolidating independent replication evidence, this review defines a curated set of robust asthma-associated miRNAs supported by convergent data across populations and phenotypes. These findings provide a basis for future efforts in endotype-aware biomarker development and inform future strategies toward miRNA-guided precision diagnostics and therapeutic interventions in asthma.


  • Open Access

    FIGURE 1 from Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment

    by Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice U. Osmanbeyoglu, Andres J. Klein-Szanto, Kathy Cai, Joseph R. Testa

    MM formation induced by crocidolite or chrysotile asbestos in mice with germline Bap1 heterozygous mutation. MM formation induced by minimal exposure to crocidolite (A and B). A,Bap1+/− and Bap1+/+ (WT) littermates injected with a total of 0.8 mg of crocidolite fibers. Left, Kaplan–Meier curves depicting survivals in Bap1+/− and Bap1+/+ groups. Right, Summary of MM incidence and median survival times. B, Results for Bap1+/− and Bap1+/+ mice injected with a total of 0.1 mg of crocidolite. Left, Kaplan–Meier curves. Right, Summary of MM incidence and median survival times. MM formation induced by high (C) and minimal (D) exposure to chrysotile. C,Bap1+/− and Bap1+/+ mice were injected with a total of 3.2 mg of chrysotile. Left, Kaplan–Meier survival curves. Right, MM incidence and median survival times. D,Bap1+/− and Bap1+/+ mice injected with a total of 0.4 mg/mouse of crocidolite. Left, Kaplan–Meier curves. Right, MM incidence and median survival times. For all Kaplan–Meier survival curves, deaths due to all causes are included. Some mice (especially WT animals) succumbed because of adhesion-related intestinal obstructions and/or liver fibrosis.

  • Open Access

    Supplementary Figure S5 from Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment

    by Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice U. Osmanbeyoglu, Andres J. Klein-Szanto, Kathy Cai, Joseph R. Testa

    Expression of arginase and iNOS in a crocidolite-exposed Bap1+/- mouse. Arginase-1 (Arg-1) staining is found mostly in mesothelioma tissue (MM), whereas iNOS staining is present primarily in the granulomatous lesions (G). Arrows indicate crocidolite fibers found in the granuloma.

  • Open Access

    FIGURE 7 from Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment

    by Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice U. Osmanbeyoglu, Andres J. Klein-Szanto, Kathy Cai, Joseph R. Testa

    Preliminary clinical connections of mouse findings based on NCI human MM RNA-seq and germline mutation data (16). A, Comparison of CCL2 mRNA expression levels based on BAP1 germline mutation status in 100 MM samples from the NCI cohort. Statistical analysis was performed using the Student t test. B, Immunoblot analyses of CCL2 in human MM cell lines with or without loss of BAP1 expression. GAPDH was used as a loading control. C, Scatter plots depicting the relationship between CD163 and CCR2, ENTPD1 (CD39), IL10, IL10RA, MRC1 (CD206), and STAT3 mRNA expression levels. Statistical analysis for this correlation study was conducted using Spearman rank-order correlations (r) and P values.

  • Open Access

    Supplementary Table S2 from Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment

    by Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice U. Osmanbeyoglu, Andres J. Klein-Szanto, Kathy Cai, Joseph R. Testa

    Summary of the ratio of asbestos-exposed mice in each cohort that developed liver fibrosis and/or other abdominal adhesions

  • Open Access

    Supplementary Figure S3 from Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment

    by Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice U. Osmanbeyoglu, Andres J. Klein-Szanto, Kathy Cai, Joseph R. Testa

    Histopathologic assessment of two representative MMs from Bap1+/− mice exposed to either crocidolite or chrysotile. Serial tumor sections depicting H&E staining and IHC for MM markers podoplanin and WT1 in a representative crocidolite-induced MM (upper panel) and a representative chrysotile-induced MM (lower panel). All original images are at 200X magnification.

  • Open Access

    FIGURE 5 from Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment

    by Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice U. Osmanbeyoglu, Andres J. Klein-Szanto, Kathy Cai, Joseph R. Testa

    IHC staining for CD39 (top; diffuse brown stain) and Ccr2 (bottom; punctate stain) in crocidolite-induced and chrysotile-induced MMs from Bap1+/− mice. Arrows indicate examples of cells positively stained for Ccr2.